DAILY VARIATION OF SERUM-LIPIDS IN RELATION TO THE CIRCADIAN-RHYTHM OF PLATELET-AGGREGATION IN HEALTHY MALE PERSONS

被引:7
作者
KNOFLER, R
URANO, T
TAMINATO, T
YOSHIMI, T
NAKANO, T
NAKAJIMA, K
TAKADA, Y
TAKADA, A
机构
[1] HAMAMATSU UNIV SCH MED, DEPT PHYSIOL, HAMAMATSU, SHIZUOKA 43131, JAPAN
[2] HAMAMATSU UNIV SCH MED, DEPT INTERNAL MED, HAMAMATSU, SHIZUOKA 43131, JAPAN
[3] JAPAN IMMUNORES LABS, TAKASAKI, GUMMA 379, JAPAN
关键词
LIPIDS; PLATELET AGGREGATION; DAILY VARIATION; HUMAN;
D O I
10.1016/0009-8981(95)06117-V
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The circadian rhythm of platelet aggregation was compared with that of serum lipids in seven healthy male persons, Daily variations of remnant lipoprotein-cholesterol and of remnant lipoprotein-triglycerides were related to those of arachidonic acid-, ADP (adenosine diphosphate)-, and collagen-induced aggregation in platelet-rich plasma and to ADP-induced aggregation in whole blood, respectively. Statistical analyses indicate that the time course of remnant-cholesterol was correlated to that of ADP-induced aggregation in platelet-rich plasma and the time courses of blood cholesterol and triglyceride were correlated to arachidonic acid- and serotonin-induced platelet aggregation in platelet-rich plasma, respectively. In whole blood, the time course of remnant lipoprotein-triglyceride was correlated only to ADP-induced platelet aggregation. In contrast, the daily variation of HDL (high density lipoprotein)-cholesterol did not influence either that of platelet aggregation in platelet-rich plasma or that in whole blood, Our findings are of clinical interest regarding the development of atherosclerosis and thrombotic events in persons with an elevated level of serum lipids.
引用
收藏
页码:109 / 119
页数:11
相关论文
共 38 条
[21]   PREVENTION OF LIPID INDUCED PLATELET-AGGREGATION BY ASPIRIN [J].
JOHNSTON, RV ;
GINER, JV ;
LOWE, GDO ;
FORBES, CD ;
PRENTICE, CRM .
THROMBOSIS RESEARCH, 1982, 27 (02) :235-239
[22]   INCREASED FREQUENCY OF LIPOPROTEIN DISORDERS SIMILAR TO TYPE-III HYPERLIPOPROTEINEMIA IN SURVIVORS OF MYOCARDIAL-INFARCTION IN JAPAN [J].
KAMEDA, K ;
MATSUZAWA, Y ;
KUBO, M ;
ISHIKAWA, K ;
MAEJIMA, I ;
YAMAMURA, T ;
YAMAMOTO, A ;
TARUI, S .
ATHEROSCLEROSIS, 1984, 51 (2-3) :241-249
[23]   REMNANTS OF LIPOPROTEINS OF INTESTINAL AND HEPATIC ORIGIN IN FAMILIAL DYSBETALIPOPROTEINEMIA [J].
KANE, JP ;
CHEN, GC ;
HAMILTON, RL ;
HARDMAN, DA ;
MALLOY, MJ ;
HAVEL, RJ .
ARTERIOSCLEROSIS, 1983, 3 (01) :47-56
[24]   IMPAIRED FIBRINOLYTIC-ACTIVITY INDUCED BY INGESTION OF BUTTER - EFFECT OF INCREASED PLASMA-LIPIDS ON THE FIBRINOLYTIC-ACTIVITY [J].
KOZIMA, Y ;
URANO, T ;
SERIZAWA, K ;
TAKADA, Y ;
TAKADA, A .
THROMBOSIS RESEARCH, 1993, 70 (02) :191-202
[25]  
KROLL MH, 1994, THROMBOSIS HEMORRHAG, P247
[26]   PLATELET AGGREGABILITY IN HUMANS - CONTRASTING INVIVO AND INVITRO FINDINGS DURING SYMPATHOADRENAL ACTIVATION AND RELATIONSHIP TO SERUM-LIPIDS [J].
LARSSON, PT ;
HJEMDAHL, P ;
OLSSON, G ;
ANGELIN, B ;
HORNSTRA, G .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1990, 20 (04) :398-405
[27]   RELATIONSHIPS BETWEEN SERUM-LIPIDS, SEROTONIN, PLATELET-AGGREGATION AND SOME FIBRINOLYTIC PARAMETERS IN HUMANS [J].
MALYSZKO, J ;
URANO, T ;
KNOFLER, R ;
IHARA, H ;
TAKADA, Y ;
TAKADA, A .
LIFE SCIENCES, 1994, 55 (21) :1619-1623
[28]  
MILLS DCB, 1981, HAEMOSTASIS THROMBOS, P50
[29]   BIOCHEMICAL, CLINICAL, AND GENETIC FEATURES OF TYPE-III HYPERLIPOPROTEINEMIA [J].
MORGANROTH, J ;
LEVY, RI ;
FREDRICKSON, DS .
ANNALS OF INTERNAL MEDICINE, 1975, 82 (02) :158-174
[30]   CHOLESTEROL IN REMNANT-LIKE LIPOPROTEINS IN HUMAN SERUM USING MONOCLONAL ANTI APO B-100 AND ANTI APO A-I IMMUNOAFFINITY MIXED GELS [J].
NAKAJIMA, K ;
SAITO, T ;
TAMURA, A ;
SUZUKI, M ;
NAKANO, T ;
ADACHI, M ;
TANAKA, A ;
TADA, N ;
NAKAMURA, H ;
CAMPOS, E ;
HAVEL, RJ .
CLINICA CHIMICA ACTA, 1993, 223 (1-2) :53-71